Menu Search
Equities

Bristol-Myers Squibb Co

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BMYB34:SAO

Bristol-Myers Squibb Co

Actions
  • Price (BRL)317.74
  • Today's Change6.06 / 1.94%
  • Shares traded477.00
  • 1 Year change-0.89%
  • Beta--
Data delayed at least 15 minutes, as of Feb 13 2026 18:23 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BMY:NYQ since
announced		Transaction
value
Orbital Therapeutics IncAnnounced10 Oct 202510 Oct 2025Announced36.17%1.50bn
2Seventy Bio IncDeal completed10 Mar 202510 Mar 2025Deal completed-0.41%238.66m
Data delayed at least 15 minutes, as of Feb 13 2026 18:23 GMT.

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
State Street Global Advisors Europe Ltd.as of 30 Jun 2025372.96k0.02%
UBS Asset Management Switzerland AGas of 31 Dec 202433.50k0.00%
UBS Asset Management (UK) Ltd.as of 30 Jun 202530.08k0.00%
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.